Baillie Gifford & CO Exact Sciences Corp Transaction History

Baillie Gifford & CO

  • $128 Billion
  • Q3 2025

A detailed history of Baillie Gifford & CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 763,356 shares of EXAS stock, worth $49.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
763,356
Previous 780,016 2.14%
Holding current value
$49.4 Million
Previous $41.5 Million 0.76%
% of portfolio
0.03%
Previous 0.03%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025
SELL
$40.91 - $56.0 $681,560 - $932,960
-16,660 Reduced 2.14%
763,356 $41.8 Million
Q2 2025

Aug 06, 2025
SELL
$40.31 - $58.08 $2.12 Million - $3.05 Million
-52,552 Reduced 6.31%
780,016 $41.5 Million
Q1 2025

May 07, 2025
SELL
$43.04 - $58.51 $7.75 Million - $10.5 Million
-180,159 Reduced 17.79%
832,568 $36 Million
Q4 2024

Jan 31, 2025
SELL
$49.33 - $71.97 $9.71 Million - $14.2 Million
-196,774 Reduced 16.27%
1,012,727 $56.9 Million
Q3 2024

Nov 05, 2024
SELL
$42.43 - $70.83 $9.21 Million - $15.4 Million
-217,116 Reduced 15.22%
1,209,501 $82.4 Million
Q2 2024

Jul 25, 2024
SELL
$41.33 - $74.26 $11.4 Million - $20.4 Million
-275,371 Reduced 16.18%
1,426,617 $60.3 Million
Q1 2024

May 01, 2024
SELL
$56.27 - $73.77 $116 Million - $152 Million
-2,065,067 Reduced 54.82%
1,701,988 $118 Million
Q4 2023

Jan 26, 2024
SELL
$59.06 - $75.72 $17.7 Million - $22.7 Million
-299,275 Reduced 7.36%
3,767,055 $279 Million
Q3 2023

Nov 13, 2023
SELL
$65.94 - $99.04 $33 Million - $49.6 Million
-500,751 Reduced 10.96%
4,066,330 $277 Million
Q2 2023

Jul 28, 2023
SELL
$62.68 - $95.05 $13.5 Million - $20.5 Million
-215,265 Reduced 4.5%
4,567,081 $429 Million
Q1 2023

May 03, 2023
SELL
$47.19 - $70.77 $7.03 Million - $10.5 Million
-148,916 Reduced 3.02%
4,782,346 $324 Million
Q4 2022

Jan 24, 2023
BUY
$30.35 - $53.15 $3.58 Million - $6.27 Million
118,025 Added 2.45%
4,931,262 $244 Million
Q3 2022

Oct 27, 2022
BUY
$31.97 - $49.37 $12.7 Million - $19.7 Million
398,730 Added 9.03%
4,813,237 $156 Million
Q2 2022

Aug 08, 2022
BUY
$35.61 - $76.23 $1.99 Million - $4.25 Million
55,787 Added 1.28%
4,414,507 $174 Million
Q1 2022

May 05, 2022
SELL
$57.56 - $82.54 $10.7 Million - $15.3 Million
-185,274 Reduced 4.08%
4,358,720 $305 Million
Q4 2021

Jan 20, 2022
BUY
$72.5 - $100.68 $6.63 Million - $9.21 Million
91,467 Added 2.05%
4,543,994 $354 Million
Q3 2021

Oct 19, 2021
SELL
$90.24 - $124.05 $1.23 Million - $1.69 Million
-13,600 Reduced 0.3%
4,452,527 $425 Million
Q2 2021

Aug 02, 2021
BUY
$93.66 - $139.27 $11.2 Million - $16.6 Million
119,101 Added 2.74%
4,466,127 $555 Million
Q1 2021

May 06, 2021
BUY
$116.57 - $155.01 $373 Million - $496 Million
3,197,782 Added 278.25%
4,347,026 $573 Million
Q4 2020

Feb 10, 2021
BUY
$99.61 - $142.12 $14 Million - $20 Million
140,565 Added 13.94%
1,149,244 $152 Million
Q3 2020

Nov 12, 2020
BUY
$72.92 - $102.01 $8.06 Million - $11.3 Million
110,518 Added 12.3%
1,008,679 $103 Million
Q2 2020

Aug 12, 2020
BUY
$55.75 - $92.75 $9.39 Million - $15.6 Million
168,454 Added 23.09%
898,161 $78.1 Million
Q1 2020

May 08, 2020
BUY
$37.9 - $104.44 $349,172 - $962,205
9,213 Added 1.28%
729,707 $42.3 Million
Q4 2019

Feb 10, 2020
BUY
$77.66 - $99.74 $8.04 Million - $10.3 Million
103,524 Added 16.78%
720,494 $66.6 Million
Q3 2019

Nov 07, 2019
SELL
$90.37 - $122.49 $8.54 Million - $11.6 Million
-94,462 Reduced 13.28%
616,970 $55.8 Million
Q2 2019

Aug 08, 2019
SELL
$89.51 - $118.04 $18.2 Million - $24 Million
-203,347 Reduced 22.23%
711,432 $84 Million
Q1 2019

May 01, 2019
BUY
$61.98 - $96.5 $1.91 Million - $2.98 Million
30,885 Added 3.49%
914,779 $0
Q4 2018

Feb 14, 2019
BUY
$56.04 - $82.66 $1.11 Million - $1.63 Million
19,765 Added 2.29%
883,894 $55.8 Million
Q3 2018

Nov 13, 2018
BUY
$48.29 - $80.6 $16 Million - $26.6 Million
330,485 Added 61.93%
864,129 $68.2 Million
Q2 2018

Jul 17, 2018
BUY
$37.84 - $69.96 $6.48 Million - $12 Million
171,351 Added 47.3%
533,644 $31.9 Million
Q1 2018

May 10, 2018
BUY
$39.82 - $57.53 $3.04 Million - $4.39 Million
76,342 Added 26.7%
362,293 $14.6 Million
Q4 2017

Feb 13, 2018
BUY
$46.49 - $60.51 $1.21 Million - $1.57 Million
26,024 Added 10.01%
285,951 $15 Million
Q3 2017

Oct 20, 2017
BUY
$37.05 - $47.12 $9.63 Million - $12.2 Million
259,927
259,927 $12.2 Million

Others Institutions Holding EXAS

# of Institutions
659
Shares Held
158M
Call Options Held
1.43M
Put Options Held
2.35M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email